Browse Title Index


 
Issue Title
 
Vol 22, No 1 (2021) A Budget Impact Analysis of the VENTANA PD-L1 SP142 Immunohistochemistry Assay Versus the Dako PD-L1 IHC 22C3 Assay in Patients With Advanced or Metastatic Triple-Negative Breast Cancer Treated With Atezolizumab in Combination With Nab-Paclitaxel Abstract   HTML   PDF
Cristian Scatena, Roberto Ravasio, Paola Raimondo, Mario Giuliano
 
Vol 13, No 1 (2012) A changing journal in a changing health care Details   HTML   PDF
Mario Eandi
 
Vol 18, No 1 (2017) A cost-effectiveness analysis of E/C/F/TAF vs three boosted regimens in the Italian context Abstract   HTML   PDF
Lorenzo Pradelli, Giovanni Di Perri, Giuliano Rizzardini, Elisa Martelli, Stefano Giardina, Massimiliano Povero
 
Vol 14, No 4 (2013) A cost-minimization analysis of combination therapy in hypertension: fixed-dose vs extemporary combinations Abstract   HTML   PDF
Marco Bellone, Pierluigi Sbarra
 
Vol 18, No 1 (2017) A general model for the estimation of societal costs of lost production and informal care in Italy Abstract   HTML   PDF
Lorenzo Pradelli, Gianni Ghetti
 
Vol 15, No 3 (2014) A new decision model for economic evaluation of novel therapies for HCV Abstract   HTML   PDF
Matteo Ruggeri, Americo Cicchetti, Silvia Coretti, Carlo Cammà, Nicola Caporaso, Antonio Gasbarrini
 
Vol 14, No 1 (2013) A pharmacoeconomic analysis of the use of single MMC instillation in low risk NMIBC in Italy Abstract   HTML   PDF
Renzo Colombo, Federico Pellucchi, Lorenzo Rocchini, Carmen Maccagnano, Pablo Katz, Valeria Pegoraro
 
Vol 13, No 2S (2012) Abruzzo Abstract   HTML   PDF
Roberto Gasparini, Donatella Panatto, Bruna Dirodi, Rosa Prato, Gianni Amunni, Valter Turello, Luigi Sudano, Paolo Cristoforoni, Sara Boccalini, Paolo Bonanni
 
Vol 9, No 1S (2008) Abruzzo Abstract   PDF
Maria Caterina Cavallo, Filippo Cipriani, Simone Gerzeli, Nadia Demarteau, Alessia Marocco, Francesco Bamfi
 
Vol 13, No 1 (2012) Access to pharmaceutical products in six European countries – analysis of different pharmaceutical distribution systems Abstract   HTML   PDF
Evelyn Walter, Aline Dragosits, Monira Said
 
Vol 18, No 1 (2017) Acknowledgement to reviewers (January - December 2017) Details   PDF
Ombretta Bandi
 
Vol 19, No 1 (2018) Acknowledgement to Reviewers (January - December 2018) Details   HTML   PDF
Ombretta Bandi
 
Vol 6, No 4 (2005) Adefovir dipivoxil nella terapia dell’epatite B cronica: profilo farmacologico clinico ed economico Abstract   PDF
Lorenzo Pradelli, Mario Eandi
 
Vol 12, No 2S (2011) Aderenza e persistenza: due elementi chiave per la determinazione dell’efficacia terapeutica in usual care Details   PDF
Giampiero Mazzaglia, Ovidio Brignoli, Achille P. Caputi, Claudio Cricelli
 
Vol 13, No 1 (2012) Adherence to therapeutic guidelines among patients treated with statins. Results from STAR study Abstract   HTML   PDF
Luca Degli Esposti, Diego Sangiorgi, Gabriele Lazzeri, Stefano Buda
 
Vol 12, No 2 (2011) Adherence to treatment and anticoagulation control in vitamin K antagonists-treated patients: an administrative databases analysis in a large Italian population Abstract   HTML   PDF
Luca Degli Esposti, Diego Sangiorgi, Giuseppe Di Pasquale, Gian Franco Gensini, Ido Iori, Stefano Buda, Ezio Degli Esposti
 
Vol 19, No 1 (2018) Albutrepenonacog alfa (Idelvion®) for the treatment of Italian patients with hemophilia B: a budget impact model Abstract   HTML   PDF
Lorenzo Pradelli, Sara Villa, Giancarlo Castaman
 
Vol 3, No 1 (2002) ALPRAZOLAM: profilo farmacoeconomico nei disturbi d’ansia e da attacchi di panico Abstract   PDF
Mario Eandi
 
Vol 20, No 1S (2019) An Integrated Management Model of Patients With Atrial Fibrillation: The Experience of the Local Health Unit Tuscany North-West Abstract   HTML   PDF
Giancarlo Casolo, Giuseppe Cavirani, Alessandro Del Carlo, Sergio Iannazzo, Massimo Pardini, Alessandro Squillace
 
Vol 1, No 2 (2000) Analisi comparativa del mercato dei dispositivi per incontinenza in cinque paesi europei Abstract   PDF
Dante Cornago, Livio Garattini
 
Vol 6, No 4 (2005) Analisi costi-efficacia di 90Y-ibritumomab tiuxetano (Zevalin®) vs. terapie attualmente disponibili nel trattamento dei pazienti affetti da Linfoma Non-Hodgkin (LNH) refrattario o recidivato Abstract   PDF
Carlo Lazzaro, Manolo Beelke
 
Vol 5, No 2 (2004) Analisi Costo Minimizzazione delle preparazioni di Interferon Beta per il trattamento della Sclerosi Multipla Abstract   PDF
Francesco Macchia, Pierluigi Russo, Luciano Caprino
 
Vol 3, No 2 (2002) Analisi costo/efficacia della doxofillina vs. teofillina nella terapia dell’asma cronica reversibile dell’adulto Abstract   PDF
Mario Eandi, Elisa Berno, Lorenzo Pradelli
 
Vol 5, No 4 (2004) Analisi costo/efficacia di sevelamer nel trattamento dell’iperfosforemia del paziente in dialisi Abstract   PDF
Mario Eandi, Nicola Giotta, Gaia Santagostino Barbone
 
Vol 6, No 4 (2005) Analisi Costo-Efficacia di Amfotericina B Liposomiale (L-AmB) versus Amfotericina B Complesso Lipidico (ABLC) nel trattamento empirico della neutropenia febbrile Abstract   PDF
Mario Eandi
 
Vol 4, No 4 (2003) Analisi dei costi di buprenorfina vs metadone nella terapia dei soggetti con dipendenza da oppiacei Abstract   PDF
Giorgio L. Colombo, Guido Faillace, Michele Ferdico
 
Vol 3, No 3 (2002) Analisi della persistenza e delle risorse allocate nel trattamento farmacologico dell’ipertensione arteriosa Abstract   PDF
Luca Degli Esposti, Alessandro Capone, Ezio Degli Esposti, Giorgio Valpiani, Mirko Di Martino, Gianluca Baio, Pierluigi Russo, Stefano Buda, Alessandra Sturani, Luciano Caprino
 
Vol 6, No 2 (2005) Analisi di costo di pemetrexed vs docetaxel nel trattamento di seconda linea del carcinoma polmonare non a piccole cellule Abstract   PDF
Roberto Ravasio
 
Vol 6, No 4 (2005) Analisi di costo efficacia nella terapia della BPCO Abstract   PDF
Sergio Iannazzo, Lorenzo Pradelli, Roberto W. Dal Negro, Mario Eandi
 
Vol 5, No 4 (2004) Analisi di minimizzazione dei costi del trattamento della leucemia cronica con fludarabina fosfato (Fludara®) e.v. e p.o.: metodologia e risultati di un’indagine empirica Abstract   PDF
Carlo Lazzaro
 
Vol 6, No 2 (2005) Analisi farmacoeconomica del trattamento di pazienti psicotici cronici con olanzapina, antipsicotici atipici e neurolettici tipici: uno studio regionale Abstract   PDF
Felice Vadruccio, Giovanni Biricolti, Leonardo Mendolicchio
 
Vol 21, No 1 (2020) Analysis of Market Access Agreements in Turkey Abstract   HTML   PDF
Guvenc Kockaya, Okan Atalay, Mustafa Kurnaz, Selin Okcun, Nazlı Sencan, Cigdem Gedik, Mete Saylan, Gulpembe Oguzhan
 
Vol 17, No 1 (2016) Analysis of the treatment cost of HIV/AIDS in Turkey Abstract   HTML   PDF
Guvenc Kockaya, Tuba Elbir Zengin, Fatma Betul Yenilmez, Canan Dalgic, Simten Malhan Simten Malhan, Pamir Cerci, Ergun Oksuz, Serhat Unal
 
Vol 11, No 2 (2010) Ankylosing spondylitis and psoriatic arthritis: clinical and economic consequences of the use of etanercept Abstract   PDF
Viola Sacchi, Orietta Zaniolo, Ignazio Olivieri
 
Vol 9, No 1S (2008) Appendice Details   PDF
Maria Caterina Cavallo, Filippo Cipriani, Simone Gerzeli, Nadia Demarteau, Alessia Marocco, Francesco Bamfi
 
Vol 3, No 2 (2002) Appropriatezza clinica ed economica: strumenti e modelli di valutazione e gestione dell’attività psichiatrica Abstract   PDF
Carmine Munizza, Salvatore Nieddu, Maurizio Bianco
 
Vol 23, No 1 (2022) Artificial Urinary Sphincters as a Treatment for Post-Prostatectomy Severe Urinary Incontinence in Italy: A Cost-Utility Analysis Abstract   HTML   PDF
Francesco Mennini, Daniele Rossi, Andrea Marcellusi
 
Vol 13, No 3 (2012) Assessment of the innovative quality of agomelatine through the Innovation Assessment Algorithm Abstract   HTML   PDF
Liliana Civalleri, Sabrina Licata
 
Vol 8, No 2 (2007) Asthma and public awareness in Italy: results from CHAOS (Chronic Airway Obstruction Survey) Abstract   PDF
Stefano Uleri, Roberto W. Dal Negro
 
Vol 8, No 1S (2007) Atti del I Convegno. Laboratorio dose unitaria Galenica clinica e gestione del rischio: modelli ed esperienze Details   PDF
Alessandro D’Arpino, Francesca Venturini, Luigi Giuliani, Ilario Viano, Oscar Alabiso, Massimo Boni, Maria Rachele Chiappetta, Stefano Federici, Franca Goffredo, Antonella Cannas, Paolo Serra
 
Vol 2, No 4 (2001) Automedicazione: una risorsa economica da valorizzare Abstract
Carlo Lucioni, Luca Zappaterra
 
Vol 13, No 2S (2012) Basilicata Abstract   HTML   PDF
Roberto Gasparini, Donatella Panatto, Bruna Dirodi, Rosa Prato, Gianni Amunni, Valter Turello, Luigi Sudano, Paolo Cristoforoni, Sara Boccalini, Paolo Bonanni
 
Vol 9, No 1S (2008) Basilicata Abstract   PDF
Maria Caterina Cavallo, Filippo Cipriani, Simone Gerzeli, Nadia Demarteau, Alessia Marocco, Francesco Bamfi
 
Vol 8, No 1 (2007) Bayesian statistic methods and theri application in probabilistic simulation models Abstract   PDF
Sergio Iannazzo
 
Vol 7, No 1 (2006) Bayesian statistic methods and theri application in probabilistic simulation models Abstract   PDF
Orietta Zaniolo, Mario Eandi
 
Vol 13, No 2S (2012) Bolzano Abstract   HTML   PDF
Roberto Gasparini, Donatella Panatto, Bruna Dirodi, Rosa Prato, Gianni Amunni, Valter Turello, Luigi Sudano, Paolo Cristoforoni, Sara Boccalini, Paolo Bonanni
 
Vol 9, No 1S (2008) Bolzano Abstract   PDF
Maria Caterina Cavallo, Filippo Cipriani, Simone Gerzeli, Nadia Demarteau, Alessia Marocco, Francesco Bamfi
 
Vol 17, No 3 (2016) Budget impact analysis of apixaban to treat and prevent venous thromboembolism in Italy Abstract   HTML   PDF
Marco Bellone, Roberto Di Virgilio, Paolo Di Rienzo
 
Vol 15, No 1S (2014) Budget impact analysis of apixaban versus other NOACs for the prevention of stroke in Italian atrial fibrillation patients Abstract   HTML   PDF
Lorenzo Pradelli, Mario Calandriello, Roberto Di Virgilio, Marco Bellone, Marco Tubaro
 
Vol 18, No 1 (2017) Budget impact analysis of dabigatran compared with rivaroxaban in the prevention of the thromboembolic risk in patients with non-valvular atrial fibrillation Abstract   HTML   PDF
Maria Grazia Celeste, Francesca De Marco, Claudio Fresco, Giuseppe Musumeci, Roberto Ravasio
 
Vol 18, No 1 (2017) Budget Impact analysis of the first-line treatment of Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) adult patients Abstract   HTML   PDF
Francesco Mennini, Andrea Marcellusi, Raffaella Viti, Giuseppe Saglio
 
Vol 17, No 1 (2016) Budget impact analysis of the use of daclatasvir in Italy for the treatment of Hepatitis C Virus (HCV) genotype 3 patients Abstract   HTML   PDF
Umberto Restelli, Alfredo Alberti, Adriano Lazzarin, Marzia Bonfanti, Carmela Nappi, Davide Croce
 
Vol 10, No 1 (2009) Budget impact analysis of the use of lapatinib in the treatment of breast cancer in Italy Abstract   PDF
Francesco Bamfi, Federica Basso, Massimo Aglietta, Carmelo Bengala, Vito Lorusso, Paolo Pronzato, Maria Caterina Cavallo, Orietta Zaniolo, Sergio Iannazzo
 
Vol 15, No 3 (2014) Budget impact analysis of the use of paricalcitol for the treatment of secondary hyperparathyroidism in chronic kidney disease Abstract   HTML   PDF
Valentina Lorenzoni, Giuseppe Turchetti
 
Vol 10, No 1 (2009) Budget impact analysis of the use of rituximab in the treatment of rheumatoid arthritis in Italy Abstract   PDF
Maurizio Benucci, Sergio Iannazzo, Luciano Sabadini
 
Vol 10, No 1 (2009) Budget impact analysis of use of aliskiren in hypertension on the Italian Health Care System Abstract   PDF
Orietta Zaniolo, Lorenzo Pradelli
 
Vol 13, No 3 (2012) Budget impact analysis resulting from the use of dabigatran etexilate in preventing stroke in patients with non-valvular atrial fibrillation in Italy Abstract   HTML   PDF
Francesco Mennini, Sergio Russo, Andrea Marcellusi
 
Vol 8, No 1 (2007) Budget impact of rosiglitazone in type 2 diabetes Abstract   PDF
Orietta Zaniolo, Francesco Bamfi, Sergio Iannazzo
 
Vol 9, No 3 (2008) Budget impact of vildagliptin Abstract   PDF
Orietta Zaniolo, Viola Sacchi, Lorenzo Pradelli
 
Vol 23, No 1 (2022) Budget Saving Potential of Pegfilgrastim Biosimilar for the Treatment of Chemotherapy-Induced Febrile Neutropenia, in Italy Abstract   HTML   PDF
Patrizia Berto, Marco Bellone, Alice Sabinot, Carmine Pinto, Massimo Martino, Daniele Generali, Pier Luigi Carriero, Maria Domenica Sanna
 
Vol 13, No 2S (2012) Calabria Abstract   HTML   PDF
Roberto Gasparini, Donatella Panatto, Bruna Dirodi, Rosa Prato, Gianni Amunni, Valter Turello, Luigi Sudano, Paolo Cristoforoni, Sara Boccalini, Paolo Bonanni
 
Vol 9, No 1S (2008) Calabria Abstract   PDF
Maria Caterina Cavallo, Filippo Cipriani, Simone Gerzeli, Nadia Demarteau, Alessia Marocco, Francesco Bamfi
 
Vol 13, No 2S (2012) Campania Abstract   HTML   PDF
Roberto Gasparini, Donatella Panatto, Bruna Dirodi, Rosa Prato, Gianni Amunni, Valter Turello, Luigi Sudano, Paolo Cristoforoni, Sara Boccalini, Paolo Bonanni
 
Vol 9, No 1S (2008) Campania Abstract   PDF
Maria Caterina Cavallo, Filippo Cipriani, Simone Gerzeli, Nadia Demarteau, Alessia Marocco, Francesco Bamfi
 
Vol 14, No 1 (2013) Can market structure explain cross-country differences in health? Abstract   HTML   PDF
Kate Rybczynski, Lori Curtis
 
Vol 13, No 1S (2012) Cetuximab in first line treatment of metastatic colorectal cancer Abstract   HTML   PDF
Carlo Barone, Andrea Belisari, Fortunato Ciardiello, Lorenzo Mantovani, Lucia D’Angiolella, Gianluca Furneri, Nicola Normanno, Patrizio Piacentini, Carmine Pinto
 
Vol 13, No 1 (2012) Clinical and economic impact of aliskiren in uncontrolled hypertensive patients Abstract   HTML   PDF
Ezio Degli Esposti, Radovan Tomic
 
Vol 12, No 2 (2011) Clinical and economic profile of entecavir in the treatment of chronic hepatitis b virus infection Abstract   HTML   PDF
Mario Eandi
 
Vol 13, No 3 (2012) Clinical and economic profile of prucalopride in the treatment of chronic constipation in women Abstract   HTML   PDF
Vincenzo Stanghellini, Mario Eandi
 
Vol 21, No 1S (2020) Clinical and Economic Rationale for the Early use of SGLT2 Inhibitors in Patients with Type 2 Diabetes Abstract   HTML   PDF
Edoardo Mannucci, Pier Paolo Mangia, Lorenzo Pradelli
 
Vol 7, No 3 (2006) Clinical and pharmacoeconomic profile of esomeprazole in acid-related diseases Abstract   PDF
Orietta Zaniolo
 
Vol 11, No 1 (2010) Clinical and pharmacoeconomic profile of lanthanum carbonate treatment of hyperphosphataemia in chronic renal dialysis patients Abstract   PDF
Mario Eandi
 
Vol 21, No 1 (2020) Clinical Impact of two Different Diagnostic Strategies in the First- and Second-Line Treatment of Locally Advanced or Metastatic EGFR-Mutated Non-Small Cell Lung Cancer Abstract   HTML   PDF
Giovanni Gancitano, Roberto Ravasio, Lorenzo Cattelino, Paolo Di Procolo, Diego Cortinovis
 
Vol 4, No 2 (2003) Commenti al lavoro di Colombo GL, Muzio A “Gli inibitori di pompa protonica nelle patologie acido-correlate: il ruolo di rabeprazolo in una strategia di cost minimisation” Details   PDF
Cristina Rossi, Giancarlo Benelli
 
Vol 6, No 3 (2005) Commenti all’articolo: “Interruzione del trattamento nei pazienti con schizofrenia che ricevono olanzapina o aripiprazolo: metanalisi degli studi clinici controllati” Details   PDF
Giovanni Battista Leproux, Michele Intorcia
 
Vol 15, No 1S (2014) Comparative pharmacoeconomic assessment of apixaban vs. standard of care for the prevention of stroke in Italian atrial fibrillation patients Abstract   HTML   PDF
Lorenzo Pradelli, Mario Calandriello, Roberto Di Virgilio, Marco Bellone, Marco Tubaro
 
Vol 16, No 3 (2015) Comparison between traditional and goal directed perfusion in cardiopulmonary by-pass. A differential cost analysis in US Abstract   HTML   PDF
Massimiliano Povero, Lorenzo Pradelli
 
Vol 16, No 1S (2015) Comparison between traditional and goal directed perfusion in cardiopulmonary by-pass. Adaptation of a differential cost analysis Abstract   HTML   PDF
Massimiliano Povero, Lorenzo Pradelli
 
Vol 4, No 3 (2003) Considerazioni cliniche ed economiche nel trattamento del cancro della prostata: analisi costo-efficacia di bicalutamide vs flutamide in combinazione con LHRH Abstract   PDF
Monia Marchetti, Giorgio Lorenzo Colombo
 
Vol 13, No 2 (2012) Consumer preferences for the predictive genetic tests for Alzheimer’s disease Abstract   HTML   PDF
Ming-Yi Huang, Matthew Perri III
 
Vol 21, No 1 (2020) Corrigendum: An Integrated Management Model of Patients With Atrial Fibrillation: The Experience of the Local Health Unit Tuscany North-West/1 Abstract   HTML   PDF
[No authors listed]
 
Vol 21, No 1 (2020) Corrigendum: An Integrated Management Model of Patients With Atrial Fibrillation: The Experience of the Local Health Unit Tuscany North-West/2 Abstract   HTML   PDF
[No authors listed]
 
Vol 20, No 1 (2019) Corrigendum: Treatments of Advanced Non‑Small Cell Lung Cancer (NSCLC) in an Italian Center: Drug Utilization and the Treatment Costs of Innovative Drugs Abstract   HTML   PDF
[No authors listed]
 
Vol 16, No 2 (2015) Cost analysis of inappropriate treatments for suspected dermatomycoses Abstract   HTML   PDF
Emanuela Fiammenghi, Angela Patalano, Viviana Lo Conte, Gabriella Calabrò
 
Vol 16, No 1 (2015) Cost differentials of dental outpatient care across clinical dentistry branches Abstract   HTML   PDF
Jovana Rančić, Nemanja Rančić, Nemanja Majstorović, Vladimir Biočanin, Marko Milosavljević, Mihajlo Jakovljević
 
Vol 20, No 1 (2019) Cost Minimization Analysis of Radiofrequency Compared to Laser Thermal Ablation in Patients with Hepatocellular Carcinoma Abstract   HTML   PDF
Maria Guarino, Lucia Sara D'Angiolella, Luigia Falco, Federica Morando, Giovan Giuseppe Di Costanzo, Filomena Morisco, Giovanni Improta, Lorenzo Giovanni Mantovani, Nicola Caporaso
 
Vol 17, No 2 (2016) Cost of care of chronic non-communicable diseases in Jamaican patients: the role of obesity Abstract   HTML   PDF
Christine M. Fray-Aiken, Rainford J. Wilks, Abdullahi O. Abdulkadri, Affette M. McCaw-Binns
 
Vol 16, No 3 (2015) Cost of illness of advanced ovarian carcinoma in Italy: results of an empirical, single-centre study Abstract   HTML   PDF
Carlo Lazzaro, Francesco Plotti, Stella Capriglione, Matteo Ferrario, Roberto Angioli
 
Vol 13, No 3 (2012) Cost of illness of community-acquired pneumonia. Review of the literature and possible strategies in the Serbian health care setting Abstract   HTML   PDF
Mihajlo Jakovljevic, Vojislav Cupurdija, Zorica Lazic
 
Vol 12, No 3 (2011) Cost of osteoporosis-related fracture in Italy. Results of the BLOCK study Abstract   HTML   PDF
Luca Degli Esposti, Silvano Adami, Giovanni Iolascon, Alfredo Nardi, Luca Pietrogrande, Giuseppina Resmini, Maurizio Rossini, Umberto Tarantino, Paolo Tranquilli Leali, Carlo Trevisan, Alessandra Cheli, Chiara Veronesi, Stefano Buda
 
Vol 11, No 2 (2010) Cost/effectiveness analysis of atorvastatin in patients with acute coronary syndromes Abstract   PDF
Simona Cammarota, Enrica Menditto, Daria Putignano, Anna Citarella
 
Vol 11, No 2 (2010) Cost/effectiveness model of dabigatran in the prevention of venous thromboembolism in major orthopedic surgery: Adaptation for Italy Abstract   PDF
Orietta Zaniolo, Sorrel E. Wolowacz, Lorenzo Pradelli
 
Vol 19, No 1 (2018) Cost-Consequence Analysis of Three Different Diagnostic Strategies in the First- and Second-Line Treatment of Locally Advanced or Metastatic Non-Small-Cell Lung Cancer Abstract   HTML   PDF
Giovanni Gancitano, Roberto Ravasio, Matteo Dionisi, Diego Cortinovis
 
Vol 22, No 1 (2021) Cost-Effectiveness Analysis of Alirocumab in High Cardiovascular-Risk Patients in Italy Abstract   HTML   PDF
Massimiliano Povero, Lorenzo Pradelli, Andrea Serra, Francesca Fanelli, Luca Gazzi
 
Vol 20, No 1 (2019) Cost-Effectiveness Analysis of Dimethyl Fumarate in the Treatment of Relapsing Remitting Multiple Sclerosis: An Italian Societal Perspective Abstract   HTML   PDF
Lorenzo Giovanni Mantovani, Gianluca Furneri, Rossella Bitonti, Paolo Cortesi, Elisa Puma, Laura Santoni, Luca Prosperini
 
Vol 18, No 1 (2017) Cost-effectiveness analysis of empagliflozin in the treatment of patients with type 2 diabetes and established cardiovascular disease in Italy, based on the results of the EMPA-REG OUTCOME study Abstract   HTML   PDF
Sergio Iannazzo, Edoardo Mannucci, Odette Reifsnider, Aldo Pietro Maggioni
 
Vol 7, No 2 (2006) Cost-effectiveness analysis of paclitaxel + carboplatin vs. alternative combinations in the treatment of non-small cell lung cancer Abstract   PDF
Mario Eandi
 
Vol 19, No 1 (2018) Cost-Effectiveness Analysis of Peginterferon Beta-1a in the Treatment of Relapsing-Remitting Multiple Sclerosis in Italy: Results of an Updated Analysis Details   HTML   PDF
Diego Centonze, Sergio Iannazzo, Laura Santoni, Cecilia Saleri, Elisa Puma, Luigi Giuliani, Pier Luigi Canonico
 
Vol 12, No 2 (2011) Cost-effectiveness evaluations of spinal neuromodulation with ziconotide continuous infusion in cancer pain in a real clinical practice Abstract   HTML   PDF
Orietta Zaniolo, Sergio Iannazzo, Gian Piero Patrucco, Roberto Bellini
 
Vol 23, No 1 (2022) Cost-Effectiveness of Dimethyl Fumarate Compared to Teriflunomide for Relapsing Remitting Multiple Sclerosis Patients in Italy Abstract   HTML   PDF
Lorenzo Giovanni Mantovani, Paolo Angelo Cortesi, Alessandra Cardillo, Laura Santoni, Luca Prosperini
 
1 - 100 of 480 Items 1 2 3 4 5 > >>